Advances in biomedical science, data science, engineering, and technology are leading to high-pace innovation with potential to transform health and medicine. These innovations simultaneously raise important ethical and social issues, including how to fairly distribute their benefits and risks. The National Academies of Sciences, Engineering, and Medicine, in collaboration with the National Academy of Medicine, established the Committee on Creating a Framework for Emerging Science, Technology, and Innovation in Health and Medicine to provide leadership and engage broad communities in developing a framework for aligning the development and use of transformative technologies with ethical and equitable principles. The committees resulting report describes a governance framework for decisions throughout the innovation life cycle to advance equitable innovation and support an ecosystem that is more responsive to the needs of a broader range of individuals and is better able to recognize and address inequities as they arise.

Table of Contents

Front Matter Summary 1 Introduction 2 Taking Equity Seriously in Innovation 3 The Innovation Life Cycle in Health and Medicine and the Challenge of Equity 4 A Governance Framework for Aligning Innovation in Health and Medicine with Equity 5 Reimagining the Innovation Life Cycle: Concrete Steps toward Equity Appendix A: Information Sources and Methods Appendix B: Technology Governance and Equity in the United States from the Cold War to COVID-19 Appendix C: Equity in Innovation within NIH and FTC: Examination of Agency Approaches and Implementation Appendix D: Committee Member and Staff Biographies Appendix E: Disclosure of Unavoidable Conflicts of Interest